Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption

Por You Park, Behzad Etemad, Hayat Ahmed, Vivek Naranbhai, Evgenia Aga, Ronald J. Bosch, John W. Mellors, Daniel R. Kuritzkes, Michael Para, Rajesh T. Gandhi, Mary Carrington, Jonathan Z. Li
Publicado em 2017-11-01

Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection

Por Noah J Silverstein, Yetao Wang, Zachary Manickas-Hill, Claudia Carbone, Ann Dauphin, Brittany P Boribong, Maggie Loiselle, Jameson Davis, Maureen M Leonard, Leticia Kuri-Cervantes, MGH COVID-19 Collection & Processing Team, Nuala J Meyer, Michael R Betts, Jonathan Z Li, Bruce D Walker, Xu G Yu, Lael M Yonker, Jeremy Luban
Publicado em 2022-03-01

Rapid establishment of a COVID-19 perinatal biorepository: early lessons from the first 100 women enrolled

Por Lydia L. Shook, Jessica E. Shui, Adeline A. Boatin, Samantha Devane, Natalie Croul, Lael M. Yonker, Juan D. Matute, Rosiane S. Lima, Muriel Schwinn, Dana Cvrk, Laurel Gardner, Robin Azevedo, Suzanne Stanton, Evan A. Bordt, Laura J. Yockey, Alessio Fasano, Jonathan Z. Li, Xu G. Yu, Anjali J. Kaimal, Paul H. Lerou, Andrea G. Edlow
Publicado em 2020-08-01

Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapy.

Por Jonathan Z Li, Brad Chapman, Patrick Charlebois, Oliver Hofmann, Brian Weiner, Alyssa J Porter, Reshmi Samuel, Saran Vardhanabhuti, Lu Zheng, Joseph Eron, Babafemi Taiwo, Michael C Zody, Matthew R Henn, Daniel R Kuritzkes, Winston Hide, ACTG A5262 Study Team, Cara C Wilson, Baiba I Berzins, Edward P Acosta, Barbara Bastow, Peter S Kim, Sarah W Read, Jennifer Janik, Debra S Meres, Michael M Lederman, Lori Mong-Kryspin, Karl E Shaw, Louis G Zimmerman, Randi Leavitt, Guy De La Rosa, Amy Jennings
Publicado em 2014-01-01